AUDENTES THERAPEUTICS, INC. (a Delaware corporation) 5,750,000 Shares of Common Stock UNDERWRITING AGREEMENT Dated: January 24, 2018Underwriting Agreement • January 25th, 2018 • Audentes Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 25th, 2018 Company Industry Jurisdiction